SCS therapies can play a role in cancer-related pain treatment despite limited evidence base
Spinal cord stimulation (SCS) therapies targeting the dorsal column “may be considered” within the multimodal treatment plans typically required by cancer patients, but it...
Proof-of-concept study indicates utility of evoked-interference DBS in Parkinson’s disease
Closed-loop evoked-interference deep brain stimulation (DBS) has been shown to be potentially utilisable in characterising the role of oscillatory dynamics in Parkinson’s disease and...
Spinal cord stimulation and other modalities will benefit from greater understanding of gender discrepancies
Despite their clear significance in pain management, gender differences relating to the ways patients respond to neuromodulation therapies are relatively poorly understood and underpinned...
Intraoperative neuromonitoring may drive a new era in spinal cord stimulation therapies
“We are entering an era where true scientific evidence from IONM is guiding technology and our clinical practice.” This was one of the...
